Effects of two immunosuppressive triple therapies on inflammatory cells in lung

F. M. Almeida, M. Prado e Silva, S. F. Soto, A. T. Correia, P. Pêgo-Fernandes, R. Pazetti (São Paulo, Brazil)

Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Session: Novel approaches in the management of lung transplant candidates and recipients
Session type: Thematic Poster Session
Number: 2461

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. M. Almeida, M. Prado e Silva, S. F. Soto, A. T. Correia, P. Pêgo-Fernandes, R. Pazetti (São Paulo, Brazil). Effects of two immunosuppressive triple therapies on inflammatory cells in lung. Eur Respir J 2014; 44: Suppl. 58, 2461

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tacrolimus increases inflammatory cells in lung
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014


Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

The effect of immunosuppression on airway integrity
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015

Effects of basiliximab and triple therapy on airway mucociliary clearance of rats
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


The influence of extracorporeal photopheresis on NFκB signaling and cytokine expression in lung transplant patients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016



Effect of enginereed GOLD nanoparticles targeted to mesenchymal cells on inflammatory response
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013

Serum cytokines patterns in lung transplant recipients
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013


Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003

Long-term outcome of lung recipients: The role of CD4+CD25highCD127- treg
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Determining factors for bronchial healing in lung transplantation
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015

LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Does perfusion with the organ care system influence inflammatory response in lung transplantation?
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014

Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Significant changes in monocyte subsets during infliximab therapy in severe sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015